Dr. Neil Bressler, James P. Gills Professor of Ophthalmology at Johns Hopkins University School of Medicine and Chief of the Retina Division at the Wilmer Eye Institute in Baltimore, Maryland will review the entire course and the goal of the program as well as review the CME information and learning objectives.

What Have We Learned about Vitrectomy for DME?

The treatment of diabetic retinopathy (DR) and retinal vein occlusion (RVO) is an increasingly complex and rapidly changing discipline with new information and techniques emerging. In addition, the incidence of DR and RVO is increasing dramatically. It is vital you remain up to date with the latest information, to insure your patients receive the optimal care. With that in mind, What's New in Diabetic Retinopathy & Retinal Vein Occlusion will review cutting edge therapies and techniques in DR and RVO.

Medicine

The treatment of diabetic retinopathy (DR) and retinal vein occlusion (RVO) is an increasingly complex and rapidly changing discipline with new information and techniques emerging. In addition, the incidence of DR and RVO is increasing dramatically. It is vital you remain up to date with the latest information, to insure your patients receive the optimal care. With that in mind, What's New in Diabetic Retinopathy &amp; Retinal Vein Occlusion will review cutting edge therapies and techniques in DR and RVO.

Share What Have We Learned about Vitrectomy for DME?

Sign up to save your podcasts

What Have We Learned about Vitrectomy for DME?

What Have We Learned about Vitrectomy for DME?